First 5 minutes and stabilization
›Immediate priorities
›Airway and breathing
›Oxygen for hypoxemia
›Anaphylaxis protocol if airway symptoms
›Circulation
›IV access for systemic toxicity
›Fluid resuscitation for shock
›Analgesia
›Acetaminophen PO 650 mg
›Ibuprofen PO 400 mg
›Time critical consult triggers
›Hand surgery for tendon sheath concern
›ENT or plastics for complex facial injury
Wound care and closure strategy
›Wound management
›Irrigation
›High volume saline irrigation
›Pressure irrigation for contaminated wounds
›Debridement
›Remove devitalized tissue
›Remove foreign bodies
›Exploration
›Evaluate tendon and joint capsule involvement
›Evaluate neurovascular injury
›Closure approach
›Primary closure options
›Face wounds with good irrigation
›Low infection risk lacerations
›Avoid primary closure scenarios
›Puncture wounds
›Hand wounds high infection risk
›Grossly contaminated wounds
›Antibiotic strategy
›Prophylaxis indications
›Hand bite
›Deep puncture
›Crush injury
›Delayed presentation more than 8 hours
›Immunocompromised host
›Treatment indications
›Cellulitis
›Abscess
›Lymphangitis
›First line oral
›Amoxicillin clavulanate
›Adult 875 mg 125 mg PO twice daily
›Prophylaxis duration 3 to 5 days
›Treatment duration 5 to 7 days
›Penicillin allergy options
›Doxycycline
›Adult 100 mg PO twice daily
›Avoid in pregnancy
›Avoid in children under 8 years
›Metronidazole
›Adult 500 mg PO twice daily
›TMP SMX
›Adult 160 mg 800 mg PO twice daily
›Clindamycin
›Adult 300 mg PO three times daily
›Pediatric examples
›Amoxicillin clavulanate
›Amoxicillin component 25 to 45 mg per kg per day divided twice daily
›Maximum per local pediatric protocol
›TMP SMX plus clindamycin
›TMP component 4 to 5 mg per kg per dose twice daily
›Clindamycin 10 mg per kg per dose three times daily
›IV antibiotics indications
›Systemic toxicity
›Rapid progression
›Deep space infection
›Tetanus prevention
›Vaccine indications
›Unknown or incomplete immunization
›More than 10 years since booster
›More than 5 years since booster for contaminated wounds
›Tetanus immune globulin indications
›Dirty wound with unknown or incomplete immunization
›Severe immunodeficiency with dirty wound
›Administration considerations
›Vaccine and immune globulin different sites
›Document product and lot if available
Rabies post exposure prophylaxis
›Rabies PEP decision and regimen
›Immediate wound cleansing
›Soap and water irrigation
›Virucidal agent if available
›Animal observation and testing logic
›Dog cat ferret available and healthy
›10 day observation local protocol dependent
›Unvaccinated regimen
›HRIG 20 IU per kg once
›Infiltrate as much as feasible into and around wound
›Remaining HRIG IM at site distant from vaccine
›Rabies vaccine IM series
›Day 0
›Day 3
›Day 7
›Day 14
›Immunocompromised regimen
›Add vaccine dose day 28
›Consider serologic confirmation per public health
›Previously vaccinated regimen
›No HRIG
›Rabies vaccine IM
›Day 0
›Day 3
›Administration pearls
›Deltoid IM adult
›Anterolateral thigh IM child
›Avoid gluteal injection
›Intradermal regimens
›Programmatic option in some settings
›Local protocol dependent
›Reassessment triggers
›Pain progression within hours
›Expanding erythema
›Fever development
›New neurologic deficits distal to wound
›Reduced range of motion
›Return evaluation window 24 to 48 hours for high risk wounds